Objective: Asthma is one of the important diseases that should be followed closely in order to prevent possible complications during pregnancy. The aim of this study was to determine the follow-up treatments of pregnant women diagnosed with asthma and to evaluate the effects of the drugs used on the fetus and the mother, the factors that trigger asthma, and the use of the correct inhaler.
Materials and Methods: Within the scope of this research, 40 pregnant women with asthma who applied to the gynecology outpatient clinic of Şişli Hamidiye Etfal T.R.H between 01/01/2022 and 31/07/2022 were evaluated. The files of the patients were reviewed retrospectively and the anamnesis, age, smoking history, diagnostic information and recommended treatment approach information and birth information in their files were analyzed.
Results: A majority of the cases (n=35, 87.5%) had been previously diagnosed with asthma and only 5 (12.5%) patients had been newly diagnosed. Twenty-five (62.5%) of the participants had used antihistamines, 9 (22.5%) salbutamol, and 6 (15%) long-acting beta-agonists + inhaled corticosteroids. Nine (22.5%) of pregnant women with asthma had an episiotomy, 16 (40%) had cesarean section, 6 (15%) had interventional delivery, 1 (2.5%) had breech delivery, 7 (17.5%) had ongoing pregnancy, and 1 (2.5%) had an abortion. While 19 (47.5%) of the asthmatic pregnant women were followed by a pulmonologist, 9 (22.5%) used medication during their pregnancy. There was a statistically significant difference between the use of drugs during pregnancy according to the age groups (Chi-square test; χ²=6.684; p=0.035). As the age of pregnant women increased, the rate of drug use during pregnancy also increased. There was a statistically significant difference between the use of drugs during pregnancy according to the status of being under the control of a chest diseases specialist of the pregnant women who participated in the study (Chi-square test; χ²=12.835; p=00001). While all of those who were not under the control of a pulmonologist did not use medication, 47.4% of those under the control of a pulmonologist used medication during their pregnancy.
Conclusion: It has been reported that the change in immunity during pregnancy cause a deterioration in the course of asthma in pregnant women with asthma. Controlling asthma is very important in preventing complications. A pregnant woman with asthma should be considered a high-risk pregnant and should be followed closely by an obstetrician and a chest disease specialist.
ORCID NO: 0000-0003-1802-3844
Anahtar Kelimeler: Asthma, pregnancy, women's health, child health, treatment
|
